Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy-Reference-Cited by-同舟云学术

Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy

Published:2022 Issue:22 Volume:14 Page:8028-8040
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

González-Rubio Sergio¹²,Salgado Cástor³,Manzaneda-González Vanesa¹,Muñoz-Úbeda Mónica¹²,Ahijado-Guzmán Rubén¹,Natale Paolo¹²^ORCID,Almendro-Vedia Víctor G.¹²,Junquera Elena¹^ORCID,Barcina José Osío³^ORCID,Ferrer Irene²⁴⁵,Guerrero-Martínez Andrés¹^ORCID,Paz-Ares Luis²⁴⁵⁶,López-Montero Iván¹²⁷^ORCID

Affiliation:

1. Departamento Química Física, Universidad Complutense de Madrid, Avda. Complutense s/n, 28040 Madrid, Spain

2. Instituto de Investigación Hospital Doce de Octubre (imas12), Avenida de Córdoba s/n, 28041 Madrid, Spain

3. Departamento Química Orgánica, Universidad Complutense de Madrid, Avda. Complutense s/n, 28040 Madrid, Spain

4. Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain

5. Ciberonc, Madrid, Spain

6. Departamento de Medicina, Universidad Complutense de Madrid, Avda. Complutense s/n, 28040 Madrid, Spain

7. Instituto Pluridisciplinar, Ps. Juan XXIII 1, 28040 Madrid, Spain

Abstract

Nano-conjugates composed of gold nanorods and nonyl acridine orange (NAO) derivatives were built as a novel approach for mitochondria targeted-cancer therapy.

Funder

H2020 European Research Council

Comunidad de Madrid

Ministerio de Ciencia e Innovación

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D2NR02353A

Reference57 articles.

1. Targeted Cancer Therapy: The Next Generation of Cancer Treatment